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Durham, NCA	shave	biopsy	with	a	razor	blade	or	
#15	scalpel	is	the	best	approach	for	a	
facial	nevus,	assuming	malignancy	is	not	
suspected.	the	resulting	scar	is	usually	
flat,	smaller	than	the	lesion,	has	no	suture	
lines,	and—if	shaved	in	mid	or	upper	
dermis—has	a	low	risk	of	producing	a	
hypertrophic	or	hypotrophic	scar	(strength	
of	recommendation:	C,	expert	opinion,	
committee	guidelines).		
Shave biopsies are quick  
and well-tolerated
If	you	suspect	malignancy	in	a	nevus,	
obtain	an	excisional	or	incisional	biopsy.	
Shave	biopsies	are	best	suited	for	raised,	
flesh-colored	nevi	and	are	generally	quick,	
well-tolerated,	and	cost-effective.	tissue	
from	a	shave	biopsy	can	be	submitted	for	
histological	evaluation.	
	 Shave	biopsies	are	preferred	by	
patients	because	there	are	no	sutures	and	
scarring	is	minimized.	the	site	may	be	pink	
and	may	take	several	months	to	develop	
a	normal	appearance.	the	final	result	may	
be	unnoticeable,	or	leave	an	indentation	or	
be	hypo-	or	hyperpigmented.	
	 Hairy,	pigmented,	and	compound	nevi	
are	likely	to	do	better	with	a	punch	biopsy.	
to	prevent	recurrence,	seek	histologic	
confirmation	that	the	entire	nevus	has	
been	removed.
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z 	Evidence summary
Numerous reports and guidelines indicate 
that if a nevus is even slightly suspicious 
for malignancy, it should be removed by 
excisional biopsy or sampled for diagno-
sis by punch or incisional biopsy. There 
are no randomized controlled trials or 
cohort studies comparing techniques for 
removing raised nevi from the face. 
Shave biopsy has good outcomes
Expert opinion and individual pro-
spective case series show acceptable 
outcomes for shave biopsy. One pro-
spective study followed 55 patients after 
removal of nevi from the head and neck. 
These nevi were removed using a shave 
procedure with a #15 scalpel and hot 
cautery for bleeding. Of the 55 sites, 4 
retained pigment and 30 had a visible 
scar with a mean diameter of 5 mm at 
6- to 8-month follow-up.1 The mean 
diameter of the original lesions was 
6 mm. There was no difference between 
the size of those lesions that scarred and 
those that didn’t.
Researchers conducting a second 
retrospective study, done at least 1 year 
after the procedure, used a questionnaire 
to ask 76 patients (with a total of 83 
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nevi removed from the face by shave 
excision) about their perceptions of 
the scar.2 Patients described their le-
sions as: no scar (33%), white and flat 
(25%), depressed (19%), raised (15%), 
and pigmented (7%). Eighty-six per-
cent thought their scars looked better 
than the nevus and 79% were “happy 
with the way the scar looks now.” Two 
additional studies, based on both pa-
tient and provider perceptions, with 
similar conclusions, are presented in 
the TablE.3,4
atypical lesions should be excised
Atypical lesions require excisional 
biopsy. The depth and architecture of 
the lesion, if melanoma, cannot be deter-
mined by shave biopsy, and both treat-
ment and prognosis depend on those 
characteristics. 
These guidelines derive from well-
designed, nonexperimental descriptive 
studies.5 However, a recent retrospective 
study compared the Breslow depth de-
termination of 4 different biopsy tech-
niques, performed by experienced der-
matologists, with the subsequent depth 
on definitive surgery for melanoma. 
This study found that superficial shave, 
deep shave, and punch biopsy predicted 
the Breslow depth 88% (95/108) of the 
time.6 As expected, excisional biopsy 
predicted the depth 100% (30/30) of 
the time. The location of the biopsy sites 
were not reported. The choice of biopsy 
was influenced by the suspicion of mel-
anoma; thin (<1 mm) melanomas were 
more likely to be superficially shaved 
than deep-shaved or punched. 
Recommendations from others
Guidelines on nevocellular nevi from 
the American Academy of Dermatology 
recommend a simple excisional or inci-
sional biopsy; they do not discuss the 
method of removal for benign appearing 
facial lesions.7 
The UK Guidelines for the Manage-
ment of Cutaneous Melanoma recom-
mend that suspicious lesions be excised 
completely (excisional biopsy) and sent 
for confirmatory histopathological ex-
amination.5 A biopsy that transects the 
depth of the lesion (for example, super-
ficial shave biopsy) should be avoided 
because histological depth of invasion is 
the basic criterion for staging and shave 
biopsy makes the staging impossible in 
some cases. n
Favorable cosmetic results following shave biopsy of facial nevi
   % wiTh rETainEd  % wiTh  
 no. PTS PigmEnT or  viSiblE follow-uP EvaluaTion/ 
STudy /nEvi rECurrEnCE   SCarring inTErval donE by
hudson- 55/55	 13	 55	 6–8	mo	 Cosmetically	acceptable/	 	
Peacock1	 	 	 	 	 patients
bong2	 76/83	 28	 67	 ≥	1	yr	 86%:	better	than	nevus/	 	
	 	 	 	 	 patients
Zanardini3	 206/	215		 4	 9	 3	mo	 90%:	excellent*		
	 	 	 	 	 9%:	good/surgeons
ferrandiz4	 Not	known/	 20†	 67	 3	mo	 98%:	better	than	nevus/	 	
	 59	 	 	 	 pts;	92%:	excellent		 	
	 	 	 	 	 or	acceptable‡/	surgeons
*		excellent	=	no	noticeable	scar,	good	=	slightly	noticeable	scar	with	normochromia	or	hypochromia,		
poor	=	depressed	scar	or	intense	dyschromia.
†	Some	lesions	not	papular.
‡		excellent	cosmetic	result	=	imperceptible	scar	without	erythema,	hyper-	or	hypo-pigmentation,		
hypertrophy	or	atrophy.	Acceptable	=	scar	better	than	original	mole.	poor	=	left	scar	worse	than	original	mole.
table
Shave biopsies are 
best suited  
for raised, flesh- 
colored nevi  
and are generally 
quick, well- 
tolerated, and 
cost-effective
Nevus on the nose.
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